Eli Lilly declares Q3 2026 dividend of $1.73 per share

• Eli Lilly (NYSE:LLY) board declares a quarterly cash dividend of $1.73 per share.
• The dividend will be paid on September 10, 2026, to shareholders of record as of August 14, 2026.
• The company maintains its commitment to capital return alongside its ongoing research and development initiatives.

Eli Lilly (NYSE:LLY) announced that its board of directors has declared a cash dividend of $1.73 per share on outstanding common stock for the third quarter of 2026.

This dividend payment aligns with the company’s recent financial performance and its stated objective of providing consistent returns to its shareholders.

The dividend is scheduled for distribution on September 10, 2026, to all shareholders of record at the close of business on August 14, 2026.

Following the announcement, Eli Lilly's share price was down 0.29% at $1,095.36.

Eli Lilly continues to focus on its core business strategy, which includes expanding its cardiometabolic portfolio and advancing clinical trials for late-stage pipeline assets.

The company has maintained a consistent history of dividend payments, reflecting its long-term financial stability and focus on sustainable growth within the global pharmaceutical market.